Abstract:

Summary and comments of the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association          SHEN Yi-nan, BAI Xue-li, MA Tao, et al. Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310009, China
Corresponding authors: BAI Xue-li, E-mail: Shirleybai57@
hotmail.com; LIANG Ting-bo, E-mail: liangtingbo@zju.edu.cn
Abstract    The Joint Congress of the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA 2017) was held from 7th to 10th June 2017 in Yokohama, Japan. Thousands of well-known specialists and scholars from the Asia-Pacific region were invited for the great event. The congress aimed to explore the latest achievements of diagnosis and treatment of hepatobiliary and pancreatic diseases from both the clinical and basic perspective. Minimally invasive and neoadjuvant therapies of hepatobiliary and pancreatic diseases, new progress of liver transplantation, in particular, caught the eyes.

Key words: Asian-Pacific Hepato-Pancreato-Biliary Association, Yokohama

摘要：

由亚太肝胆胰协会（A-PHPBA）主办的“第六届亚太肝胆胰学术大会”于6月7日-10日在日本横滨举行。环亚太地区上千位国际知名学者共襄盛会。会议分别从临床和基础的角度探讨了肝胆胰疾病诊疗方面的最新成果。其中，尤以肝胆胰恶性肿瘤的微创治疗、新辅助治疗以及肝脏移植领域的新进展格外引人关注。

关键词: 亚太肝胆胰协会, 横滨